Key result
COVID-19 pandemic linked to ~94% perceived reduction in ACS patients seeking acute care.
Why the study?
The COVID-19 pandemic drained resources, altered healthcare priorities, and required redeployment of resources from noncommunicable diseases to COVID-19-related healthcare services. Understanding the impact of the first COVID wave on the management of ACS in Tamil Nadu motivated this study.
How did the first wave of the COVID-19 pandemic impact the presentation and management of patients with acute coronary syndrome among interventional cardiologists in Tamil Nadu, India?
Cross-Sectional (n=101)
Yes
How did the first wave of the COVID-19 pandemic impact the presentation and management of patients with acute coronary syndrome among interventional cardiologists in Tamil Nadu, India?
This survey highlights substantial disruptions to acute coronary syndrome care in Southern India during the first COVID-19 wave, marked by delayed STEMI presentations and reduced primary PCI volume.
Answers are grounded in this paper and cite their sources.
Survey data indicate perceived ACS care disruptions in Tamil Nadu; leaves open effects on outcomes and optimal resource strategies.
Background: The COVID-19 pandemic has transformed the medical society in many ways. With significant drain on the resources and altered healthcare priorities, there is a greater need for redeployment of the resources from noncommunicable diseases to COVID-19-related healthcare services. To understand the impact of the COVID-19 pandemic on the management of acute coronary syndrome (ACS) in Tamil Nadu, a survey was administered across cardiologists in Tamil Nadu. Methods: A survey was done using an electronic questionnaire administered regarding the change of patterns of acute coronary syndromes during the COVID through Google Forms with responses collected in excel format. Results: Among 256 cardiologists contacted, 101 responded to the survey. Among cardiologists who responded, all were interventional cardiologists– with most of them performing primary percutaneous coronary intervention (PCI) (95%) regularly during pre-COVID times. Most of them have noticed a significant reduction in the number of patients with ACS seeking health care (94%) and another 61% of respondents felt that there was a reduction in the number of patients with acute coronary syndrome. There was a significant delay in ST-segment elevation myocardial infarction presentation to the hospital (88%) and significant reduction in the number of primary PCI (47%). Only 19% of respondents did primary PCI for COVID-positive patients. Conclusions: COVID pandemic has emerged as a big challenge to the global health care system. Optimal acute coronary care could not be delivered in a timely manner due to multiple social, patient, and physician-related factors. The emerging techniques in rapid diagnosis of COVID-19 and protective measures of COVID infection are expected to improve the situation. Trial Registration: Clinical Trials Registry – India (CTRI), CTRI/2020/09/027517, Registered September 1, 2020 http://CTRI.nic.In/Clinicaltrials/pmaindet2. php? trialid = 47025 and EncHid = and user Name =.
No takes yet. Share an insight, caveat, or question.
Muralidharan et al. (2021) conducted a cross-sectional in Acute coronary syndrome management during the COVID-19 pandemic (n=101). First wave of the COVID-19 pandemic vs. Pre-COVID period was evaluated on Perceived reduction in patients with acute coronary syndrome seeking healthcare and undergoing primary PCI. The COVID-19 pandemic led to a perceived reduction in ACS patients seeking care, delayed STEMI presentation, and fewer primary PCIs among surveyed cardiologists.
Synapse has enriched 10 related papers. Consider them for comparative context: